Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Experimental eye drops help blind mice see again

Scientists have created light-activated drugs that helped blind mice perceive light again and restored visually guided behavior without gene therapy, implants, or specialized lighting. Even more intriguingly, two of the most promising compounds worked when administered as eye drops, pointing toward a potentially simple new approach to restoring vision.

We haven't written up this one. ScienceDaily Health has the full story — the link below goes straight to it.

Read the original at sciencedaily.com →

More in Health & Medicine

Samsung Bioepis Initiates Phase 1 Clinical Trial for SB35, A Biosimilar Candidate Referencing Taltz (Ixekizumab)

Samsung Bioepis Co., Ltd. announced on Aug. 28 the initiation of Phase 1 clinical trial for SB35, a biosimilar candidate referencing Taltz (ixekizumab).The Phase 1 clinical trial for SB35 is a…

  • Samsung Bioepis begins Phase 1 trial for SB35 biosimilar on August 28
  • Study compares pharmacokinetics, safety, tolerability, immunogenicity of SB35 vs Taltz
  • Primary outcomes measured: AUCinf, Cmax, AUClast from Day 1 to Day 85

More from Friday 28 August →